Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon
BM Wenk, HA Mbunkah, NN Nsanwe… - Journal of …, 2021 - academic.oup.com
Abstract Objectives In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI)
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
BM Wenk, HA Mbunkah, NN Nsanwe… - The Journal of …, 2020 - folia.unifr.ch
METHODS Fingerprick dried blood spot samples were collected from 339 newly diagnosed
HIV-1-infected individuals between 2015 and 2016 in four hospitals in Cameroon. Universal …
HIV-1-infected individuals between 2015 and 2016 in four hospitals in Cameroon. Universal …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
BM Wenk, HA Mbunkah, NN Nsanwe, ET Mbu… - 2020 - cabidigitallibrary.org
Abstract Objectives: In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI)
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
BM Wenk, HA Mbunkah, NN Nsanwe… - The Journal of …, 2021 - europepmc.org
Objectives In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI) dolutegravir was
recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …
recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
BM Wenk, HA Mbunkah, NN Nsanwe, ET Mbu… - The Journal of …, 2020 - sonar.ch
METHODS Fingerprick dried blood spot samples were collected from 339 newly diagnosed
HIV-1-infected individuals between 2015 and 2016 in four hospitals in Cameroon. Universal …
HIV-1-infected individuals between 2015 and 2016 in four hospitals in Cameroon. Universal …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon
BM Wenk, HA Mbunkah, NN Nsanwe… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI) dolutegravir was
recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …
recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon
BM Wenk, HA Mbunkah, NN Nsanwe… - Journal of …, 2021 - academic.oup.com
Abstract Objectives In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI)
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
dolutegravir was recently introduced for the treatment of HIV-1 infection. Since pretreatment …
Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon
BM Wenk, HA Mbunkah, NN Nsanwe, ET Mbu… - Journal of Antimicrobial …, 2021 - zora.uzh.ch
OBJECTIVES In Cameroon, the integrase (IN) strand transfer inhibitor (INSTI) dolutegravir
was recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …
was recently introduced for the treatment of HIV-1 infection. Since pretreatment HIV-1 drug …